Explore our portfolio

Our portfolio is made up of a diverse range of companies born from the University of Oxford’s world-leading knowledge and research. 

Whether it’s a spinout company bringing intellectual property to market, or a startup founded through our Incubator, each one has been enabled by our expertise. Together they represent one of the most diverse and dynamic university innovation ecosystems in the world.

We play a central role in bringing companies to life, and we also manage the University’s shareholdings in the companies on its behalf. 

2024

Global Pathogen Analysis Service (GPAS)

GPAS is now part of EIT Pathogena, a cutting-edge genomic analysis platform for academics and public health professionals around the world to help fight infectious diseases.

Incorporated: August 2024

Origin: Oxford University, Nuffield Department of Medicine

Sector: Health Tech, Social Impact

https://www.eit-pathogena.com

Granza Bio Corporation

A new era in cancer therapeutics by developing personalised and targeted cancer treatments using the body's own immune system.

Incorporated: July 2024

Origin: Oxford University, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS)

Sector: Life Sciences

https://www.granzabio.com/

Your Staff Know

A quick, low-cost way to increase revenue, profitability, and employee satisfaction.


 

Incorporated: June 2024

Sector: Software & AI

https://yourstaffknow.com/

Eterna Biologics

Harnessing the power of CRISPR to develop the next generation of RNA therapeutics.


 

Incorporated: June 2024

Sector: Life Sciences

https://www.eternabiologics.com/

Oxford StemTech

World-leading biotech company pioneering iPSC reprogramming and personalized regenerative medicine.

Incorporated: June 2024

Origin: Oxford University, Nuffield Department of Clinical Neurosciences

Sector: Life Sciences

https://www.oxfordstemtech.com/

Streamline Media

Music industry cloud-based media asset management system.


 

Incorporated: May 2024

Sector: Software & AI

https://www.streamline-media.net/

Chronos Therapeutics (TheraCryf)

Developing innovative therapeutics in brain disorders.

Incorporated: April 2024

Origin: Oxford University

Sector: Life Sciences

https://theracryf.com/

RQBio Covid

Developing monoclonal antibodies for instant, long-lasting immunity, protecting vulnerable people from infectious diseases.

Incorporated: April 2024

Sector: Life Sciences

https://www.rqbiotechnology.com/

Vivid Dx (formerly Ramanomics)

Diagnostics built on a Raman-spectroscopy-powered single cell identification for bacteria and fungi.


 

Incorporated: April 2024

Sector: Health Tech

https://www.vivid-dx.com/

NantBio

Developing treatments using molecularly targeted drugs tailored to the specific molecular profile of a patient's tumour.


 

Incorporated: April 2024

Sector: Life Sciences

https://nantworks.com/

TheraCryf

Developing innovative therapeutics in oncology and behavioural brain disorders.


 

Incorporated: April 2024

https://theracryf.com/

Kodiform Therapeutics

Developing small-molecule drugs targeting cancer-linked disordered proteins.


 

Incorporated: March 2024

Origin: Oxford University

Sector: Life Sciences